amperozide has been researched along with 6-chloro-2-(1-piperazinyl)pyrazine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albinsson, A; Andersson, G; Palazidou, E; Stephenson, J | 1 |
| Meltzer, HY; Willins, DL | 1 |
2 other study(ies) available for amperozide and 6-chloro-2-(1-piperazinyl)pyrazine
| Article | Year |
|---|---|
Involvement of the 5-HT2 receptor in the 5-HT receptor-mediated stimulation of prolactin release.
Topics: Amphetamines; Animals; Dose-Response Relationship, Drug; Drug Interactions; Male; Piperazines; Prolactin; Pyrazines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Ritanserin; Serotonin Antagonists; Serotonin Receptor Agonists | 1994 |
Serotonin 5-HT2C agonists selectively inhibit morphine-induced dopamine efflux in the nucleus accumbens.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amphetamines; Animals; Cocaine; Dopamine; Dopamine Uptake Inhibitors; Male; Microdialysis; Morphine; Narcotic Antagonists; Nucleus Accumbens; Piperazines; Pyrazines; Rats; Rats, Sprague-Dawley; Serotonin Antagonists; Serotonin Receptor Agonists | 1998 |